To assess whether a transformation to aggressive lymphoma had occurred in our NFAT2-deficient TCL1 cohort, we performed an immunohistochemical analysis of spleens from mice at different stages of disease development (Fig. 4 and Supplementary Fig. 6). This evidence concerns the gene NFATC1 and lymphoma.